News

A new study highlights the urgency to implement better access and distribution of naloxone to avert witnessed opioid overdose deaths.

Dr. Yan noted that increased public awareness among patients and health care providers was essential for earlier detection of melanoma.

Experts explain the societal, systemic, and clinical challenges that come with managing skin disease in people of color.

More than half of dermatology practices have separated in recent years, which has influenced how skin of color and other areas of dermatology study are taught across the United States.

The program has returned with a renewed focus for Black and skin of color-dominant residency programs in addition to those with limited access to mentorship resources.

Dr. Shankar speaks to how physician training and patient conversations can evolve in dermatology through progressive antiracism efforts.

Previous studies reported that skin and soft tissue infections were common among persons experiencing homelessness.

Dr. Lipner says that primary investigators and sub-investigators can advocate for the diversification of clinical trial participants.

People with skin of color are often presumed to suffer fewer negative effects from solar radiation, making the importance of photoprotection in this population understudied and underestimated.

New US county data suggest more general and family physicians per capita is positively linked to increased rates of full COVID-19 vaccination.

Steffen Schmitz-Valckenberg, MD, explains the close association between disease progression and uncovered risk alleles.

There was no differences in the incidence of all-cause neonatal hospitalization, post neonatal hospitalizations after birth, congenital anomalies, or infant mortality.

Patients with a positive genetic test showed higher mortality rates compared to genotype-negative patients.

New guidelines recommend healthcare providers develop and implement an individualized nutrition care plan for individuals with diabetes with or at risk of a DFU.

Qbtech is hoping to address some gaps in testing and screening for the specific symptoms of ADHD in individuals aged 6-60.

If approved, dupilumab will be the first biologic medicine available in the US to treat uncontrolled moderate-to-severe atopic dermatitis for young children 6 months to 5 years old.

Veeral S. Sheth, MD, MBA, discusses the potential value of complement inhibitors for the at-need patient population.

Dr. Osunkwo details advancements in the field of sickle cell disease, including chronic disease-managing therapies and stem cell transplant and gene therapies.

Investigators detailed personally mediated, institutional, and internalized antiracism practices that could be applicable to medicine.

Investigators developed a new method to identify potential treatments for hundreds of diseases by profiling drugs approved by the FDA.

Our third and final episode on physician burnout traces the path towards a solution and ultimately, reformation in the system as a whole.

The treatment met the pre-specified primary endpoint of significantly less weight gain in the ENLIGHTEN-Early trial.

Practice separation is occurring more frequently in medium- and large-sized practice groups and among early- and late-career dermatologists.

Barnesiella was positively associated with the first principal component, and category fluency.

There was an elevated risk of violence perpetration in both men and women with schizophrenia spectrum disorder.

Patients with asthma and bronchiectasis were more likely to have chronic rhinosinusitis than patients without bronchiectasis, according to investigators.

A higher percentages of patients treated with tirzepatide had HbA1c less than 7% versus those treated with placebo (85%-90% versus 34%).

Within the first year of the pandemic, total patients in the emergency department with a violent penetrating injury significantly increased—disproportionately so for people of color.